Cingulate Therapeutics Appoints Strategic Finance Veteran Louis G. Van Horn as Chief Financial Officer

KANSAS CITY, Kan., July 10, 2017 -- (Healthcare Sales & Marketing Network) -- Cingulate Therapeutics, LLC, a clinical stage biopharmaceutical company focused on the development of new and innovative products for the treatment of Attention Deficit/Hyperact... Biopharmaceuticals, Personnel Cingulate Therapeutics, Dexmethylphenidate, Dextroamphetamine, ADHD
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news